Imperial College London


Faculty of MedicineDepartment of Medicine

Professor of Haemostasis & Thrombosis



+44 (0)20 3313 2178m.laffan




Mrs Lisa Pape +44 (0)20 3313 1320




5S5bHammersmith HospitalHammersmith Campus





Michael Laffan is Professor of Haemostasis and Thrombosis in the department of haematology.He trained in medicine at the University of Oxford and trained in haematology at the Hammersmith and Royal Free hospitals. His principal research interests are the structure function relationship of von Willebrand factor, in particular the role of glycosylation, and the mechanisms and regulation of thrombin generation. He is director of the Hammersmith Hospital Haemophilia centre and is responsible for  postgraduate education in haematology. 



Arachchillage DR, Laffan M, 2017, Pathogenesis and management of antiphospholipid syndrome., Br J Haematol

Griffiths S, Woo C, Mansoubi V, et al., 2017, Thromboelastography (TEG (R)) demonstrates that tinzaparin 4500 international units has no detectable anticoagulant activity after caesarean section, International Journal of Obstetric Anesthesia, Vol:29, ISSN:0959-289X, Pages:50-56

Nowak AA, O'Brien HER, Henne P, et al., 2017, ADAMTS-13 glycans and conformation-dependent activity., J Thromb Haemost

Randi AM, Laffan MA, 2017, Von Willebrand factor and angiogenesis: basic and applied issues, Journal of Thrombosis and Haemostasis, Vol:15, ISSN:1538-7933, Pages:13-20

Sivapalaratnam S, Westbury SK, Stephens JC, et al., 2017, Rare variants in GP1BB are responsible for autosomal dominant macrothrombocytopenia, Blood, Vol:129, ISSN:0006-4971, Pages:520-524

More Publications